China’s Yangling Jinhai Biotechnology Co., Ltd. plans to build a plant in Kyrgyzstan to produce foot-and-mouth disease (FMD) vaccines, according to the country’s Ministry of Water Resources, Agriculture, and Processing Industry. The announcement followed a meeting between Kyrgyzstan’s Deputy Chairman of the Cabinet of Ministers and Minister of Water Resources, Agriculture, and Processing Industry, Bakyt Torobaev, and a delegation from the Chinese company.
The project includes the entire production cycle, from raising and fattening livestock to vaccination and slaughtering.
Yangling Jinhai Biotechnology Co., Ltd. is ready to invest in plant construction, transfer advanced technologies, and train local specialists.
The parties agreed to establish a working group to implement the project.
According to the World Organization for Animal Health,FMD is a severe and highly contagious viral livestock disease with a significant economic impact. It is a transboundary animal disease that profoundly affects livestock production and disrupts regional and international trade in animals and animal products.
The parties emphasized the project’s importance for strengthening Kyrgyzstan’s veterinary security, as domestically produced vaccines would significantly reduce the spread of infectious diseases among farm animals.
Kyrgyzstan is an agricultural country, and livestock farming is the country’s primary source of income for its rural population.
In September 2024, the Ministry of Water Resources, Agriculture and Processing Industry reported that Kyrgyzstan had 1,802,299 head of cattle (cows), 542,527 horses, 6,216,125 sheep and goats, 6,988,968 poultry, and 29,676 pigs.
